Response to: "The Role of Quantitative Systems Pharmacology in the Design of First-in-Human Trials"

Clin Pharmacol Ther. 2018 Nov;104(5):798. doi: 10.1002/cpt.1148. Epub 2018 Jul 14.

Authors

Kevin Blake¹, Milton Bonelli¹, Stefano Ponzano¹, Harald Enzmann²; European Medicines Agency Committee for Human Medicinal Products “First-in-Human Guideline Drafting Group”

Collaborators

European Medicines Agency Committee for Human Medicinal Products “First-in-Human Guideline Drafting Group”:
Jan-Willem van der Laan, David Jones, Lutz Wiesner, Ulla Wändel-Liminga, Kirsty Wydenbach, Elke Stahl, Walter Janssens, Dominique Masset, Joelle El-Khoury, Philippe Vella, Jan Welink

Affiliations

¹ European Medicines Agency, London, UK.
² The Federal Institute for Drugs and Medical Devices, Bonn, Germany.

PMID: 30007034
DOI: 10.1002/cpt.1148

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Discovery*
European Union
Humans
Systems Biology*